← All organizations

Chromaderm, Inc.

For profit

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

Last known activity

Mar 1, 2006

Defunct as of Mar 1, 2016

Timeline

2010s

Jun 1, 2014
Chromaderm, Inc.— Founded
Mar 1, 2016
Chromaderm, Inc.— Defunct

Drugs by trial phase (1 distinct, 10 trials)

Phase 3 (1 own, 0 via acquisition)

ruboxistaurin mesylate

Indications

Studied for

Recent trials (15)

NCT00297401Lead sponsorPhase 3Mar 1, 2006
NCT00297401Study directorPhase 3Mar 1, 2006
NCT00266695Study directorPhase 3Jan 1, 2006
NCT00266695Lead sponsorPhase 3Jan 1, 2006
NCT00133952Lead sponsorPhase 3Aug 1, 2005
NCT00133952Study directorPhase 3Aug 1, 2005
NCT00190970Lead sponsorPhase 2Oct 1, 2004
NCT00090519Study directorPhase 3Feb 1, 2004
NCT00090519Lead sponsorPhase 3Feb 1, 2004
NCT00482976Lead sponsorPhase 2Dec 1, 2003
NCT00552227Lead sponsorPhase 1Sep 1, 2002
NCT00044148Lead sponsorPhase 2Jul 16, 2002
NCT00044408Lead sponsorPhase 3Jul 1, 2002
NCT00604383Lead sponsorPhase 3Mar 1, 2001
NCT00604383Study directorPhase 3Mar 1, 2001

Details

Founded: Cambridge, MA, US Jun 1, 2014
Last known activity: Mar 1, 2006